DNTH
Price
$21.45
Change
-$0.22 (-1.02%)
Updated
Apr 28 closing price
Capitalization
689.1M
LRMR
Price
$2.35
Change
+$0.02 (+0.86%)
Updated
Apr 28 closing price
Capitalization
150.47M
9 days until earnings call
Ad is loading...

DNTH vs LRMR

Header iconDNTH vs LRMR Comparison
Open Charts DNTH vs LRMRBanner chart's image
Dianthus Therapeutics
Price$21.45
Change-$0.22 (-1.02%)
Volume$347.33K
Capitalization689.1M
Larimar Therapeutics
Price$2.35
Change+$0.02 (+0.86%)
Volume$692.83K
Capitalization150.47M
DNTH vs LRMR Comparison Chart
Loading...
DNTH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LRMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DNTH vs. LRMR commentary
Apr 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DNTH is a Buy and LRMR is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 29, 2025
Stock price -- (DNTH: $21.45 vs. LRMR: $2.35)
Brand notoriety: DNTH and LRMR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DNTH: 90% vs. LRMR: 78%
Market capitalization -- DNTH: $689.1M vs. LRMR: $150.47M
DNTH [@Biotechnology] is valued at $689.1M. LRMR’s [@Biotechnology] market capitalization is $150.47M. The market cap for tickers in the [@Biotechnology] industry ranges from $272.64B to $0. The average market capitalization across the [@Biotechnology] industry is $2.15B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DNTH’s FA Score shows that 0 FA rating(s) are green whileLRMR’s FA Score has 1 green FA rating(s).

  • DNTH’s FA Score: 0 green, 5 red.
  • LRMR’s FA Score: 1 green, 4 red.
According to our system of comparison, DNTH is a better buy in the long-term than LRMR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DNTH’s TA Score shows that 6 TA indicator(s) are bullish while LRMR’s TA Score has 4 bullish TA indicator(s).

  • DNTH’s TA Score: 6 bullish, 4 bearish.
  • LRMR’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, DNTH is a better buy in the short-term than LRMR.

Price Growth

DNTH (@Biotechnology) experienced а +4.89% price change this week, while LRMR (@Biotechnology) price change was +16.92% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.96%. For the same industry, the average monthly price growth was -1.16%, and the average quarterly price growth was -9.88%.

Reported Earning Dates

DNTH is expected to report earnings on Mar 11, 2025.

LRMR is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+7.96% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DNTH($689M) has a higher market cap than LRMR($150M). DNTH YTD gains are higher at: -1.605 vs. LRMR (-39.276). LRMR has higher annual earnings (EBITDA): -73.44M vs. DNTH (-101.45M). DNTH has more cash in the bank: 275M vs. LRMR (204M). DNTH has less debt than LRMR: DNTH (1.49M) vs LRMR (5.36M). DNTH has higher revenues than LRMR: DNTH (6.24M) vs LRMR (0).
DNTHLRMRDNTH / LRMR
Capitalization689M150M459%
EBITDA-101.45M-73.44M138%
Gain YTD-1.605-39.2764%
P/E Ratio3.24N/A-
Revenue6.24M0-
Total Cash275M204M135%
Total Debt1.49M5.36M28%
FUNDAMENTALS RATINGS
DNTH vs LRMR: Fundamental Ratings
DNTH
LRMR
OUTLOOK RATING
1..100
1227
VALUATION
overvalued / fair valued / undervalued
1..100
57
Fair valued
19
Undervalued
PROFIT vs RISK RATING
1..100
42100
SMR RATING
1..100
92100
PRICE GROWTH RATING
1..100
4665
P/E GROWTH RATING
1..100
61100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

LRMR's Valuation (19) in the null industry is somewhat better than the same rating for DNTH (57). This means that LRMR’s stock grew somewhat faster than DNTH’s over the last 12 months.

DNTH's Profit vs Risk Rating (42) in the null industry is somewhat better than the same rating for LRMR (100). This means that DNTH’s stock grew somewhat faster than LRMR’s over the last 12 months.

DNTH's SMR Rating (92) in the null industry is in the same range as LRMR (100). This means that DNTH’s stock grew similarly to LRMR’s over the last 12 months.

DNTH's Price Growth Rating (46) in the null industry is in the same range as LRMR (65). This means that DNTH’s stock grew similarly to LRMR’s over the last 12 months.

DNTH's P/E Growth Rating (61) in the null industry is somewhat better than the same rating for LRMR (100). This means that DNTH’s stock grew somewhat faster than LRMR’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
DNTHLRMR
RSI
ODDS (%)
Bullish Trend 1 day ago
88%
Bullish Trend 1 day ago
83%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
79%
MACD
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
89%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
84%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
85%
Advances
ODDS (%)
Bullish Trend 8 days ago
79%
Bullish Trend 8 days ago
86%
Declines
ODDS (%)
Bearish Trend 6 days ago
88%
Bearish Trend 22 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
86%
View a ticker or compare two or three
Ad is loading...
DNTH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LRMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PSBMX22.79N/A
N/A
Principal SmallCap R3
VLEQX10.60N/A
N/A
Villere Equity
SSFRX412.71N/A
N/A
State Street Equity 500 Index R
NEAIX43.66N/A
N/A
Needham Aggressive Growth Institutional
LSMNX12.44N/A
N/A
Loomis Sayles Small/Mid Cap Growth N

DNTH and

Correlation & Price change

A.I.dvisor indicates that over the last year, DNTH has been loosely correlated with PRME. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if DNTH jumps, then PRME could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DNTH
1D Price
Change %
DNTH100%
-1.02%
PRME - DNTH
46%
Loosely correlated
-1.78%
IMNM - DNTH
46%
Loosely correlated
+2.14%
COGT - DNTH
44%
Loosely correlated
+5.82%
ERAS - DNTH
44%
Loosely correlated
+0.72%
LRMR - DNTH
44%
Loosely correlated
+0.86%
More

LRMR and

Correlation & Price change

A.I.dvisor indicates that over the last year, LRMR has been loosely correlated with IMNM. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if LRMR jumps, then IMNM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LRMR
1D Price
Change %
LRMR100%
+0.86%
IMNM - LRMR
47%
Loosely correlated
+2.14%
SVRA - LRMR
46%
Loosely correlated
+0.31%
ERAS - LRMR
46%
Loosely correlated
+0.72%
ACLX - LRMR
46%
Loosely correlated
+1.32%
PRME - LRMR
44%
Loosely correlated
-1.78%
More